These innovative therapies , Tirzepatide , represent a significant advancement in managing metabolic dysfunction and conceivably other ailments . They all are grouped as GLP-1 pathway activators , meaning they to mimic the endogenous GLP-1 peptide, enhancing insulin release and lowering food inta